Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: A Report from the ESC-EHRA EORP-AF General Long-Term Registry

Marco Proietti^*, Giulio Francesco Romiti, Marco Vitolo, Tatjana S. Potpara, Giuseppe Boriani, Gregory Y.H. Lip, ESC-EHRA EORP-AF Long-Term General Registry Investigators, Sam Riahi (Member of study group), Albert Marni Joensen (Member of study group), Anders Gammelmark (Member of study group), Lars Hvilsted Rasmussen (Member of study group), Pia Thisted Dinesen (Member of study group), Stine Krogh Venø (Member of study group), Bodil Ginnerup Sørensen (Member of study group), Anne Marie Korsgaard (Member of study group), Karen Petrea Andersen (Member of study group), Camilla Fragtrup Hellum (Member of study group)